Pharmacology & ToxicologybioRxivPreprint
Design and evaluation of novel 4-anilinoquinolines and quinazolines as EGFR inhibitors in lung cancer and chordoma
Christopher R. M. Asquith, Kaitlyn A. Maffuid, Tuomo Laitinen…·William J. Zuercher
The paper designs and evaluates novel 4-anilinoquinolines and quinazolines as EGFR inhibitors, identifying a potent compound for lung cancer and chordoma treatment.
DOI 10.1101/545525